{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:50:06Z","timestamp":1787647806541,"version":"build-2736575974"},"reference-count":29,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,6,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To report prevalence rates of acanthosis nigricans (AN) and hyperinsulinemia and the association of AN with hyperinsulinemia compared with other known or suspected risk factors for type 2 diabetes in young American Indians.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014A random sample of Cherokee Nation members aged 5\u201340 years was invited to participate in the Cherokee Diabetes Study, a cross-sectional study of type 2 diabetes and its risk factors in a young American Indian population. Data were collected by personal interview, medical history, physical examination (including anthropometric and blood pressure measurements and examination of the neck for AN), and laboratory analyses of blood specimens. Levels of insulin, lipids, and glucose were measured on fasting blood specimens. Diabetes status was determined according to the American Diabetes Association criteria.<\/jats:p>\n               <jats:p>RESULTS\u2014A total of 2,205 participants were examined. Overall prevalence rates for AN and hyperinsulinemia were 34.2 and 47.2%, respectively. In general, the rates for both increased with age and degree of Indian heritage and were higher in female subjects, overweight\/obese individuals, those with type 2 diabetes, and those with a parental history of type 2 diabetes. In addition, both had significantly higher age- and sex-adjusted means for selected known or suspected risk factors for type 2 diabetes. AN remained significantly associated with hyperinsulinemia (P = 0.0001) in multivariate analysis.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014AN is independently associated with hyperinsulinemia and therefore may be useful as an early indicator of high risk for diabetes.<\/jats:p>","DOI":"10.2337\/diacare.25.6.1009","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"1009-1014","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":81,"title":["Association of Acanthosis Nigricans With Hyperinsulinemia Compared With Other Selected Risk Factors for Type 2 Diabetes in Cherokee Indians"],"prefix":"10.2337","volume":"25","author":[{"given":"Martha L.","family":"Stoddart","sequence":"first","affiliation":[{"name":"Center for American Indian Health Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen S.","family":"Blevins","sequence":"additional","affiliation":[{"name":"Center for American Indian Health Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa T.","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for American Indian Health Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for American Indian Health Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers R.","family":"Blackett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031214132062600_R1","doi-asserted-by":"crossref","unstructured":"Joslin EP: The universality of diabetes. JAMA\u2008115:2033\u20132038, 1940","DOI":"10.1001\/jama.1940.02810500001001"},{"key":"2022031214132062600_R2","doi-asserted-by":"crossref","unstructured":"Lillioja S, Bogardus C: Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev\u20084:517\u2013540, 1988","DOI":"10.1002\/dmr.5610040508"},{"key":"2022031214132062600_R3","doi-asserted-by":"crossref","unstructured":"Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev\u20086:1\u201327, 1990","DOI":"10.1002\/dmr.5610060101"},{"key":"2022031214132062600_R4","doi-asserted-by":"crossref","unstructured":"Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ, Yeh J, Go O, Robbins DC, Welty TK: Diabetes and impaired glucose tolerance in three American Indian populations aged 45\u201374 years. Diabetes Care\u200818:599\u2013610, 1995","DOI":"10.2337\/diacare.18.5.599"},{"key":"2022031214132062600_R5","doi-asserted-by":"crossref","unstructured":"Dabelea D, Hanson RL, Bennett PH, Roumain J, Knowler WC, Pettitt DJ: Increasing prevalence of type II diabetes in American Indian children. Diabetologia\u200841:904\u2013910, 1998","DOI":"10.1007\/s001250051006"},{"key":"2022031214132062600_R6","doi-asserted-by":"crossref","unstructured":"Savage PJ, Bennett PH, Senter GR, Miller M: High prevalence of diabetes in young Pima Indians. Diabetes\u200828:937\u2013942, 1979","DOI":"10.2337\/diabetes.28.10.937"},{"key":"2022031214132062600_R7","doi-asserted-by":"crossref","unstructured":"American Diabetes Association: Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care\u200823:381\u2013389, 2000","DOI":"10.2337\/diacare.23.3.381"},{"key":"2022031214132062600_R8","doi-asserted-by":"crossref","unstructured":"Sedano HO, Gorlin RJ: Acanthosis nigricans. Oral Med Oral Pathol\u200863:462\u2013467, 1987","DOI":"10.1016\/0030-4220(87)90259-3"},{"key":"2022031214132062600_R9","doi-asserted-by":"crossref","unstructured":"Schwartz RA: Acanthosis nigricans. J Am Acad Dermatol\u200831:1\u201319, 1994","DOI":"10.1016\/S0190-9622(94)70128-8"},{"key":"2022031214132062600_R10","doi-asserted-by":"crossref","unstructured":"Richards GE, Cavallo A, Meyer WJ, Prince MJ, Peters EJ, Stuart CA, Smith ER: Obesity, acanthosis nigricans, insulin resistance and hyperandrogenemia: pediatric perspective and natural history. J Pediatr\u2008107:893\u2013897, 1985","DOI":"10.1016\/S0022-3476(85)80182-7"},{"key":"2022031214132062600_R11","doi-asserted-by":"crossref","unstructured":"Mukhtar Q, Cleverley G, Voorhees RE, McGrath JW: Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health\u200828:372\u2013376, 2001","DOI":"10.1016\/S1054-139X(00)00217-2"},{"key":"2022031214132062600_R12","doi-asserted-by":"crossref","unstructured":"Hud JA, Cohen JB, Wagner JM, Cruz PD: Prevalence and significance of acanthosis nigricans in an adult obese population. Arch Dermatol\u2008128:941\u2013944, 1992","DOI":"10.1001\/archderm.128.7.941"},{"key":"2022031214132062600_R13","doi-asserted-by":"crossref","unstructured":"Flier JS: Metabolic importance of acanthosis nigricans. Arch Dermatol\u2008121:193\u2013194, 1985","DOI":"10.1001\/archderm.121.2.193"},{"key":"2022031214132062600_R14","unstructured":"Acanthosis Nigricans: In Textbook of Dermatology. Rook A, Wilkinson DS, Ebling FJG, Eds. Oxford, U.K., Blackwell Scientific, 1979, p.1307\u20131310"},{"key":"2022031214132062600_R15","doi-asserted-by":"crossref","unstructured":"Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M: Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr\u200837:73\u201380, 1998","DOI":"10.1177\/000992289803700203"},{"key":"2022031214132062600_R16","doi-asserted-by":"crossref","unstructured":"Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM: Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk. Am J Public Health\u200884:1839\u20131842, 1994","DOI":"10.2105\/AJPH.84.11.1839"},{"key":"2022031214132062600_R17","doi-asserted-by":"crossref","unstructured":"Burke JP, Hale DE, Hazuda HP, Stern MP: A quantitative scale of acanthosis nigricans. Diabetes Care\u200822:1655\u20131659, 1999","DOI":"10.2337\/diacare.22.10.1655"},{"key":"2022031214132062600_R18","doi-asserted-by":"crossref","unstructured":"Stuart CA, Pate CJ, Peters EJ: Prevalence of acanthosis nigricans in an unselected population. Am J Med\u200887:269\u2013272, 1989","DOI":"10.1016\/S0002-9343(89)80149-4"},{"key":"2022031214132062600_R19","doi-asserted-by":"crossref","unstructured":"Burke JP, Duggirala R, Hale DE, Blangero J, Stern MP: Genetic basis of acanthosis nigricans in Mexican Americans and its association with phenotypes related to type 2 diabetes. Hum Genet\u2008106:467\u2013472, 2000","DOI":"10.1007\/s004390000274"},{"key":"2022031214132062600_R20","doi-asserted-by":"crossref","unstructured":"Wang CS, Alaupovic P, Gregg RE, Brewer HB Jr: Studies on the mechanism of hypertriglyceridemia in Tangier disease: determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes. Biochim Biophys Acta\u2008920:9\u201319, 1987","DOI":"10.1016\/0005-2760(87)90305-5"},{"key":"2022031214132062600_R21","unstructured":"Lipid research clinics program. In Manual of Laboratory Operations. Vol. 1: Lipid and Lipoprotein Analysis. Bethesda, MD, National Institutes of Health, 1974 (DHEW publ. no.75-628)"},{"key":"2022031214132062600_R22","doi-asserted-by":"crossref","unstructured":"Friedewald W, Levy R, Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem\u200818:499\u2013502, 1972","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"2022031214132062600_R23","doi-asserted-by":"crossref","unstructured":"Sobey W, Beer S, Carrington C, Clark P, Frank B, Gray I, Luzio S, Owens D, Schneider A, Siddle K: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J\u2008260:535\u2013541, 1989","DOI":"10.1042\/bj2600535"},{"key":"2022031214132062600_R24","doi-asserted-by":"crossref","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care\u200820:1183\u20131197, 1997","DOI":"10.2337\/diacare.20.7.1183"},{"key":"2022031214132062600_R25","doi-asserted-by":"crossref","unstructured":"Dietz WH, Bellizzi MC: Introduction: the use of body mass index to assess obesity in children. Am J Clin Nutr\u200870 (Suppl.):173S\u2013175S, 1999","DOI":"10.1093\/ajcn\/70.1.173s"},{"key":"2022031214132062600_R26","unstructured":"Kuczmarski R, Ogden C, Grummer-Strawn L, Flegal K, Guo S, Wei R, Mei Z, Curtin L, Roche A, Johnson C: CDC growth charts: United States. Adv Data\u2008314:1\u201328, 2000"},{"key":"2022031214132062600_R27","doi-asserted-by":"crossref","unstructured":"Flier JS, Eastman RC, Minaker KL, Matteson D, Rowe JW: Acanthosis nigricans in obese women with hyperandrogenism. Diabetes\u200834:101\u2013107, 1985","DOI":"10.2337\/diabetes.34.2.101"},{"key":"2022031214132062600_R28","doi-asserted-by":"crossref","unstructured":"Arslanian SA, Kalhan SC: Correlations between fatty acid and glucose metabolism: potential explanation of insulin resistance of puberty. Diabetes\u200843:908\u20139l4, 1994","DOI":"10.2337\/diabetes.43.7.908"},{"key":"2022031214132062600_R29","doi-asserted-by":"crossref","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med\u2008346:393\u2013403, 2002","DOI":"10.1056\/NEJMoa012512"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/25\/6\/1009\/589569\/dc0602001009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/25\/6\/1009\/589569\/dc0602001009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T14:13:30Z","timestamp":1647094410000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/25\/6\/1009\/21282\/Association-of-Acanthosis-Nigricans-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.25.6.1009","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,1]]}}}